Call Me Cannabinoids provides in-depth information on science, business, and regulations in the rapidly-growing CBD space.

#5: Standardizing Cannabis Potency Tests for Greater Accuracy with Roni Attali, Ph.D

In this episode of Call Me Cannabinoids, Pete sat down with Roni Attali, Ph.D, the lead R&D scientist for Israel’s GemmaCert. Roni and Pete discuss the differences between the cannabis industries in Israel versus the United States, the need for more standardized, accurate potency tests for cannabis, and what the future holds for cannabis...

#3: Hemp CBD: Navigating an Uncertain Regulatory Landscape with Frank Lampe

On today’s episode of Call Me Cannabinoids, we’re joined by Frank Lampe, Vice President of Communications & Industry Relations at United Natural Products Alliance. Frank talked with our host, Pete Thornton, about hemp’s staying power in the marketplace, the coming FDA regulations surrounding hemp-derived CBD, and how CBD companies can...

#1: Hemp-Derived CBD for Clinical Application with Connor Scott of Endourage

In our first episode of Call Me Cannabinoids, we sat down with Connor Scott of Endourage to talk about the Endourage brand, using CBD in clinical applications, and how to qualify a good CBD product. Let’s dive in! About Endourage Endourage, a CBD company based in Wheatridge, Colorado, formulates tinctures and topical cream with a focus on the...

Introducing the Call Me Cannabinoids Podcast

We’re excited to introduce our new podcast, Call Me Cannabinoids, where we interview experts in the CBD industry. In today’s episode, our host, Pete Thornton, gives us an overview of the series, including what to expect from future episodes. Call Me Cannabinoids will bring us in-depth information on science, business, and regulations in the...

Invest With Us

Location

Chattanooga, TN